# VA Medicinal Cannabis Research Act of 2023

This bill would allow the Department of Veterans Affairs to conduct research on medicinal cannabis and its potential benefits for treating veterans. Right now, federal law makes it difficult for the VA to study cannabis, even though many veterans and their doctors believe it might help with conditions like chronic pain, PTSD, and other service-related injuries. This bill would remove those barriers and let the VA run clinical trials and studies to figure out whether cannabis actually works as a medical treatment.

The practical effect is that veterans could potentially gain access to cannabis-based treatments if the research shows they're safe and effective. Currently, many veterans turn to cannabis on their own or travel to states where it's legal, often without medical guidance. By allowing the VA to study cannabis properly, the government could develop evidence-based treatment options and provide veterans with medical supervision if they use it. This would be especially important for veterans struggling with pain management or mental health issues who might benefit from alternatives to opioids or other medications.

The bill also recognizes that some veterans are already using cannabis for medical purposes in states where it's legal, but they can't get help from the VA system because of federal restrictions. By opening the door to research, this legislation aims to bridge that gap and give the VA the ability to understand cannabis's real effects, potential risks, and best practices for treating veterans. It's essentially saying: let's study this carefully rather than leaving veterans to figure it out on their own.

VA Medicinal Cannabis Research Act of 2023

Tester, Jon

VA Medicinal Cannabis Research Act of 2023 This bill requires the Department of Veterans Affairs (VA) to study the effects of cannabis on veterans who are enrolled in the VA health care system and have been diagnosed with post-traumatic stress disorder (PTSD) or chronic pain (i.e., eligible veterans). First, the bill requires the VA to conduct an observational, 18-month study on the effects of cannabis on the health outcomes of eligible veterans. The VA must report on the study and address whether it is able to meet criteria necessary to conduct clinical trials. Then, if the VA determines that it is able to proceed, it must carry out a series of clinical trials on the effects of cannabis appropriate for investigational use, as determined by the Food and Drug Administration, on the outcomes of eligible veterans. The VA must carry out a long-term observational study of the clinical trial participants. The VA may terminate the trials if it is unable to meet clinical guideline requirements or the trials would create excessive risk to participants. The VA must ensure that the study and trials are representative of the demographics of veterans in the United States, as determined by the most recent data from the American Community Survey of the Bureau of the Census. The study and trials must include mechanisms to ensure data preservation and registration as necessary (in an anonymous form).